Literature DB >> 17606856

Chronic kidney disease: effects on the cardiovascular system.

Ernesto L Schiffrin1, Mark L Lipman, Johannes F E Mann.   

Abstract

Accelerated cardiovascular disease is a frequent complication of renal disease. Chronic kidney disease promotes hypertension and dyslipidemia, which in turn can contribute to the progression of renal failure. Furthermore, diabetic nephropathy is the leading cause of renal failure in developed countries. Together, hypertension, dyslipidemia, and diabetes are major risk factors for the development of endothelial dysfunction and progression of atherosclerosis. Inflammatory mediators are often elevated and the renin-angiotensin system is frequently activated in chronic kidney disease, which likely contributes through enhanced production of reactive oxygen species to the accelerated atherosclerosis observed in chronic kidney disease. Promoters of calcification are increased and inhibitors of calcification are reduced, which favors metastatic vascular calcification, an important participant in vascular injury associated with end-stage renal disease. Accelerated atherosclerosis will then lead to increased prevalence of coronary artery disease, heart failure, stroke, and peripheral arterial disease. Consequently, subjects with chronic renal failure are exposed to increased morbidity and mortality as a result of cardiovascular events. Prevention and treatment of cardiovascular disease are major considerations in the management of individuals with chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17606856     DOI: 10.1161/CIRCULATIONAHA.106.678342

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  439 in total

1.  Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women.

Authors:  Richard D Semba; Jeffrey C Fink; Kai Sun; Anne R Cappola; Mansi Dalal; Candace Crasto; Luigi Ferrucci; Linda P Fried
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy.

Authors:  Maki Shinzawa; Ryohei Yamamoto; Yasuyuki Nagasawa; Tatsuya Shoji; Yoshitsugu Obi; Tomoko Namba; Harumi Kitamura; Tetsuya Kaneko; Noriyuki Okada; Hirotsugu Iwatani; Atsushi Yamauchi; Yoshiharu Tsubakihara; Enyu Imai; Yoshitaka Isaka; Hiromi Rakugi
Journal:  Clin Exp Nephrol       Date:  2011-11-11       Impact factor: 2.801

3.  Exercise and diseased kidneys: are they compatible?

Authors:  David G Edwards
Journal:  J Physiol       Date:  2011-12-15       Impact factor: 5.182

4.  Association between age-related decline of kidney function and plasma malondialdehyde.

Authors:  Guolin Li; Yaqin Chen; Hui Hu; Li Liu; Xiaofei Hu; Jun Wang; Wang Shi; Dazhong Yin
Journal:  Rejuvenation Res       Date:  2012-04-24       Impact factor: 4.663

5.  Incidence and prognosis of resistant hypertension in hypertensive patients.

Authors:  Stacie L Daugherty; J David Powers; David J Magid; Heather M Tavel; Frederick A Masoudi; Karen L Margolis; Patrick J O'Connor; Joe V Selby; P Michael Ho
Journal:  Circulation       Date:  2012-02-29       Impact factor: 29.690

6.  Chronic kidney disease and risk for coronary events: value of myocardial perfusion imaging.

Authors:  George A Beller
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

7.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

8.  Short-term aerobic exercise and vascular function in CKD stage 3: a randomized controlled trial.

Authors:  Samuel Headley; Michael Germain; Richard Wood; Jyovani Joubert; Charles Milch; Elizabeth Evans; Anthony Poindexter; Allen Cornelius; Britton Brewer; Linda S Pescatello; Beth Parker
Journal:  Am J Kidney Dis       Date:  2014-04-26       Impact factor: 8.860

9.  Effect of icodextrin on heart rate variability in diabetic patients on peritoneal dialysis.

Authors:  Oscar Orihuela; María de Jesús Ventura; Marcela Ávila-Díaz; Alejandra Cisneros; Marlén Vicenté-Martínez; María-del-Carmen Furlong; Zuzel García-González; Diana Villanueva; Guadalupe Alcántara; Bengt Lindholm; Elvia García-López; Cleva Villanueva; Ramón Paniagua
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

10.  Are levels of NT-proBNP and SDMA useful to determine diastolic dysfunction in chronic kidney disease and renal transplant patients?

Authors:  Lidija Memon; Vesna Spasojevic-Kalimanovska; Natasa Bogavac Stanojevic; Jelena Kotur-Stevuljevic; Sanja Simic-Ogrizovic; Vojislav Giga; Violeta Dopsaj; Zorana Jelic-Ivanovic; Slavica Spasic
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.